David Hung
2021
In 2021, David Hung earned a total compensation of $4.8M as President and Chief Executive Officer at Nuvation Bio, a 310% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $618,750 |
---|---|
Option Awards | $3,594,205 |
Salary | $550,000 |
Other | $9,430 |
Total | $4,772,385 |
Hung received $3.6M in option awards, accounting for 75% of the total pay in 2021.
Hung also received $618.8K in non-equity incentive plan, $550K in salary and $9.4K in other compensation.
Rankings
In 2021, David Hung's compensation ranked 2,759th out of 12,415 executives tracked by ExecPay. In other words, Hung earned more than 77.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,759 out of 12,415 | 78th |
Division Manufacturing | 1,092 out of 5,508 | 80th |
Major group Chemicals And Allied Products | 430 out of 2,378 | 82nd |
Industry group Drugs | 375 out of 2,099 | 82nd |
Industry Pharmaceutical Preparations | 251 out of 1,549 | 84th |
Source: SEC filing on April 4, 2022.
Hung's colleagues
We found two more compensation records of executives who worked with David Hung at Nuvation Bio in 2021.